Beat Childhood Cancer at Penn State College of Medicine Launches AI-Powered Patient Engagement Platform with WeTrials to Expand Access to Pediatric Cancer Clinical Trials
Collaboration aims to advance patient-centered clinical research, making it more accessible, understandable and actionable for families HERSHEY, Pa. — Tuesday, July 7, 2026 — Beat Childhood Cancer (BCC) at Penn[...]
Penn State advances pediatric cancer research through new targeted therapy collaboration
Penn State College of Medicine is advancing its commitment to cutting-edge cancer research and early-phase clinical trials through a new collaboration aimed at accelerating a promising targeted therapy for pediatric brain[...]
Penn State’s Beat Childhood Cancer Research Consortium welcomes SJD Pediatric Cancer Center Barcelona, strengthening global leadership in pediatric cancer research
The Pediatric Cancer Center Barcelona (PCCB) at Hospital Sant Joan de Déu has become the first center outside North America to join the Beat Childhood Cancer (BCC) Research Consortium, an international pediatric cancer research[...]
Penn State College of Medicine, Beat Childhood Cancer Research Consortium and Four Diamonds launch clinical trial that aims to combat solid tumors
In a step toward fighting solid tumors in children and young adults, Penn State College of Medicine, the Beat Childhood Cancer Research Consortium and Four Diamonds, along with Senhwa Biosciences, Inc. are launching a pioneering clinical[...]
Q&A: Finding novel therapies for childhood cancer
Since the first time she treated a child with neuroblastoma, Giselle Saulnier Sholler wanted to do the impossible for her patients. Neuroblastoma is the most common extracranial solid tumor in children with[...]
FDA approves pediatric neuroblastoma drug based on Penn State professor’s work
Giselle Saulnier Sholler, professor of pediatrics and of pharmacology, reflects on 20 years working to change cancer outcomes for children HERSHEY, Pa. — In 2003, the first year of her[...]
US WorldMeds Announces FDA Approval of IWILFIN™ (eflornithine) to Strengthen Fight Against Aggressive Childhood Cancer
LOUISVILLE, Ky.--(BUSINESS WIRE)--USWM, LLC (US WorldMeds) today announced that the U.S. Food and Drug Administration (FDA) has approved IWILFIN™ (eflornithine) 192 mg tablets, a groundbreaking oral maintenance therapy for high-risk[...]
Penn State Health recruits leading researcher to fight pediatric cancer
Cris Collingwood//August 2, 2023 An internationally known physician-scientist and her research consortium have joined Penn State Health to continue efforts to eradicate pediatric cancer. Penn State Health and Penn State College of Medicine[...]
The Power of Will
Will Lacey was just a baby when doctors diagnosed a rare form of cancer and told his family there was only one end. Nobody then could imagine the journey ahead,[...]
Michigan Child Trials Target Genetic Roots of Cancers
Thank you Detroit News for featuring a story about the work we are doing. It wouldn’t be possible without the support of Dell, TGen Foundation and our generous community. Together,[...]
Research: Beat Childhood Cancer
The Beat Childhood Cancer Research Consortium is a team of hospitals in US/Canada/Brazil/Spain bringing Precision Medicine, new trials and hope to children with cancer!
Day 30 and the final day of Pediatric Cancer Awareness Month. 💛
Some of the few faces of the many children who inspire us.
They are Warriors. They are Mighty. They are Brave. They are Resilient. They are Hope.
Today marks the end of Pediatric Cancer Awareness Month, but not the end of our fight. Every child deserves a future free from cancer.
#pediatriccancerawarenessmonth #beatchildhoodcancer #ChildhoodCancerAwarenessMonth
🎗️ Day 29 of Pediatric Cancer Awareness Month
Meet Nate and learn about his personal childhood cancer journey, from patient to advocate for the next generation of children facing cancer. Today, Nate shares how his own experiences inspired a passion for research and ultimately led him to join the Beat Childhood Cancer Research Consortium Lab as a Research Technician. His story is a powerful reminder that survivors don't just overcome cancer, they often help shape the future of pediatric cancer research.
#pediatriccancerawarenessmonth #childhoodcancerawareness #beatchildhoodcancer #pediatriccancerresearch #frompatienttoresearcher
Day 28: Meet Tonia!
While her work may happen behind the scenes, Tonia plays a critical role in helping the Consortium move its mission forward. From managing grants and contracts to overseeing financial processes and resources, she helps ensure that the infrastructure supporting our work is strong, responsible, and sustainable.
This Childhood Cancer Awareness Month, we’re grateful for the many people who contribute to the mission in different ways. Tonia’s expertise, dedication, and stewardship help make that mission possible.
Hear Tonia’s thoughts on Childhood Cancer Awareness Month 💛🎗️
Day 26 of Pediatric Cancer Awareness Month 💛
This week, Divya and Riley attended the 35th SOCRA Annual Meeting in Denver, Colorado, joining clinical research professionals from across the country for three days of education, networking, and professional development.
They presented a poster on our “Biospecimen Quality Oversight in a Multi-Site Pediatric Oncology Consortium: Challenges, Strategies, and Lessons Learned”.
Advancing pediatric cancer research requires more than innovative science. It depends on well-trained research teams who continuously learn, collaborate, and share best practices to bring safe, high-quality clinical trials to children and families. Opportunities like the SOCRA Annual Meeting help strengthen the skills and partnerships that drive progress in childhood cancer research.
#pediatriccancerawarenessmonth #ChildhoodCancerAwareness #beatchildhoodcancer #ClinicalResearch #socra2026 #pediatriccancerresearch #ResearchMatters
Day 25: From Patient to Discovery
Many of the children and families who visit our Pediatric Oncology Translational Research Lab (POTRL) have made an important contribution to pediatric cancer research by donating samples to help advance scientific discovery. We love having the opportunity to welcome them into the lab, show them where samples are carefully stored and studied, and share the incredible work being done behind the scenes.
These visits help connect families with the research they make possible every day. It is inspiring to show them how their participation contributes to a growing body of knowledge that is helping researchers better understand childhood cancers and develop new treatments for future patients. We are deeply grateful to every child and family who partners with us in the fight against pediatric cancer. 🎗️🔬💛
#pediatriccancerawarenessmonth #childhoodcancerawareness #pediatriccancerresearch #biorepository #translationalresearch #HopeThroughResearch #partnersinresearch
Day 24 of Pediatric Cancer Awareness Month 🎗️
Meet Dr. Jackie Kraveka, Vice Chair of BCC, a member of our BCC Executive Committee, and our lead investigator in Charleston, SC.
In this video, Dr. Kraveka shares what inspires her, highlights important cancer statistics, discusses the impact of research, and speaks about the work that remains—particularly in low- and middle-income countries.
Join us as we hear her perspective on the progress being made and the continued need for research, collaboration, and access to care for children with cancer around the world. 💛